FDA Approves Once-Weekly GLP-1 Diabetes Treatment Regimen for T2DM

Dulaglutide is a member of the glucagon-like peptide (GLP-1) receptor agonist class, along with liraglutide, exenatide, and albiglutide. The US Food and Drug Administration (FDA) has approved dulaglutide (Trulicity) as a once a week injection for the treatment of adults with type 2 diabetes.

Posted in Type II Drugs